select article GS-01-Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease: The LUBIPRONE, doubleblind, randomized, placebo-controlled, phase II study Conference abstractNo access GS-01-Efficacy, safety, and tolerability of lubiprostone for the trea...